Address And Details

40 East 52nd Street , New York, NY 10022
Fund Manager Team Managed
Manager Tenure

Strategy And Objective

The investment objective of BlackRock Advantage Small Cap Growth Fund ( Advantage Small Cap Growth or the Fund ), a series of BlackRock FundsSM (the Trust ), is to seek long-term capital growth. Under normal circumstances, the Fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in equity securities of small cap companies and at least 80% of its net assets (plus any borrowings for investment purposes) in securities or instruments of issuers located in the United States. Equity securities consist primarily of common stock, preferred stock, securities convertible into common stock and securities or other instruments whose price is linked to the value of common stock, such as derivatives. The Fund seeks to buy primarily common stock but also can invest in preferred stock, convertible securities and other equity securities. The Fund management team focuses on small capitalization companies that Fund management believes have above average prospects for earnings growth. Although a universal definition of small-capitalization companies does not exist, the Fund generally defines these companies as those with market capitalizations, at the time of the Fund s investment, comparable in size to the companies in the Russell 2000 Index (between approximately $11.8 million and $13.3 billion as of December 31, 2020). In the future, the Fund may define small-capitalization companies using a different index or classification system. From time to time the Fund may invest in shares of companies through new issues or initial public offerings ( IPOs ). The Fund may use derivatives, including options, warrants, futures, swaps and forward contracts both to seek to increase the return of the Fund and to hedge (or protect) the value of its assets against adverse movements in currency exchange rates, interest rates and movements in the securities markets. In order to manage cash flows into or out of the Fund effectively, the Fund may buy and sell financial futures contracts or options on such contracts. Derivatives are financial instruments whose value is derived from another security, a commodity (such as oil or gas), a currency or an index, including but not limited to the Russell 2000 Index. The use of options, futures, swaps and forward contracts can be effective in protecting or enhancing the value of the Fund s assets. The Fund also may use indexed or inverse securities.

Net Asset Value

as of 6:00 PM ET 09/17/2021

Performance

  • 1 Week
  • +0.82%
  • 1 Month
  • +4.80%
  • 3 Months
  • +0.23%
  • 1 Yr Return
  • +30.05%
  • 5 Yr Return
  • +47.81%

Equity Sector Breakdown

Technology 23.64%
Health 19.22%
RetailTrade 11.79%
Services 10.75%
IndustrialCyclical 10.13%
Finance 4.36%
ConsumerDurables 3.57%
NonDurables 3.27%
Energy 1.21%
Utilities 0.80%

Asset Allocation

Asset Type % Of Allocation
Stocks 98.97%
ForeignStocks 0.48%
Preferred 0.16%
Cash 0.00%
Bonds 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 755.94 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -6.01 -2.81 -4.00
Beta 1.25 1.22 1.25
R Squared 0.81 0.75 0.75
Std Deviation 25.73 21.19 19.35
Sharpe Ratio 0.64 0.90 n/a

Purchase Information

as of 5:53 PM ET 09/16/2021
Minimum Initial $2000000
Minimum Additional $0
Minimum Initial IRA $0

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +35.70%
  • +50.72%
+35.70% +50.72%
3 Year
  • +14.05%
  • +18.08%
+14.05% +18.08%
10 Year
  • +15.04%
  • +13.29%
+15.04% +13.29%
Life Of Fund
  • +10.69%
  • +10.82%
+10.69% +10.82%

Top 10 Holdings

Symbol Company Name % Of Assets
SLAB SILICON LABORATORIES 1.73%
CROX CROCS INC 1.31%
EME EMCOR GROUP 1.23%
LSCC LATTICE SEMICONDUCTOR CORP 1.07%
WERN WERNER ENTERPRISE INC 1.05%
NVRO NEVRO CORP 1.01%
VRNS VARONIS SYSTEMS INC 1.00%
POWI POWER INTEGRATIONS INC 0.96%
AEO AMERICAN EAGLE OUTFITTERS IN 0.96%
SHAK SHAKE SHACK INC 0.92%

Recent Articles from TheStreet

AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment

AstraZeneca Stock Rises on Progress With Breast-Cancer Treatment

AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.

Cryptocurrency Lead

Cryptocurrency Price Check: Bitcoin Tumbles on Evergrande Woes

Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.

China Aims To Strengthen Its Semiconductor Supply Chain With New Standards Group That Includes Huawei, SMIC

Brooks Automation Stock Jumps on Plan to Sell Chip Solutions Unit for $3B

Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.

DR Horton, Verizon, HCA Holdings Top Analysts' Actions Monday

DR Horton Trims 2021 Sales Forecast Amid Supply Chain Disruptions

DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.

11. Colgate-Palmolive

Colgate-Palmolive Underappreciated, Deutsche Bank Says, Lifting to Buy

Colgate-Palmolive stock was upgraded to buy with an $86 price target at Deutsche Bank.

Watch Jim Cramer Live 9/20

Video: Jim Cramer on the Market Selloff, Evergrande, Debt Ceiling, Fed, Pfizer

Jim Cramer discusses the market selloff, Evergrande, debt ceiling talks, the upcoming Federal Reserve meeting, Pfizer and more in his latest video interview with TheStreet.

Wynn Lead

Wynn Resorts 'Worth Risk' of Macau Restrictions, Morgan Stanley Says

Wynn Resorts faces regulatory uncertainty in Macau, but Morgan Stanley says the casino operator is still 'worth the risk.'

Chinese Tesla Challenger Xpeng Prices Its P5 Sedan From US$24,700 After Subsidies As Battle For EV Buyers Intensifies

Tesla Wider Self-Driving Effort Reportedly Opposed by NTSB Chief

Tesla wants to expand its autonomous-driving effort to help cars make their way through cities, not just highways.

BioNTech and Pfizer's mRNA-based vaccine candidate BNT162b2 has proven to be more than 90 per cent effective in preventing Covid-19 infections. Photo: Reuters

Premarket Movers Monday - Pfizer, Netflix, Li Auto, AstraZeneca

Stocks moving in premarket trading Monday include Pfizer, Netflix, Li Auto, AstraZeneca and Bank of America.

Evergrande Group Lead

China Faces 'Lehman Moment' With Evergrande Collapse, So What Are The Risks?

'Lehman moment' or managed failure? Either result has global markets rattled by the impending default of property developer China Evergrande.